Hadassah

Research in Service to Humanity: Hadassah’s DNA

Thursday, Sep 1 2016

Prof. Eyal Mishani

How can we stop the lethal recurrence of melanoma? How can we prevent a fatal heart-valve disorder from occurring? How can we know before we administer a lung cancer treatment whether it will be effective? How can we prompt pancreatic cells to produce more insulin? These are just a few of the scientific questions being explored by the Hadassah Medical Center’s physician/researchers.

From the initial laboratory study to the human clinical trial, a wide tapestry of innovative research is a chief hallmark at Hadassah.

As Prof. Eyal Mishani, Director of Hadassah’s Department of Research and Development, explains: “For Hadassah, there is a golden triangle in which education and research go hand in hand with clinical excellence. We believe that cutting-edge medicine is practiced when physicians are actively involved in research.”

With this culture of research so central to Hadassah’s DNA:

  • Hadassah researchers receive over 60 percent of the National Science Foundation awards for biomedical research in Israeli hospitals.
  • This year, Hadassah researchers have been awarded 17 million dollars in grants and donations.
  • Hadassah researchers publish 500 to 700 scientific papers annually.
  • 200 sponsored clinical studies and 300 investigator-initiated studies are conducted each year.
  • Hadassah researchers have hundreds of patents for diagnostic and therapeutic devices.
  • Seven products are on the market and 30 more are in development.

For a larger picture of the breadth of Hadassah research, see, “A Culture of Research” in Hadassah Magazine.

 

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Jun 20 2017

Rising Genetics Star Receives Prestigious Award

Hadassah Hospital Geneticist Dr. Tamar Harel, who is looking into the underlying genetic reasons for rare diseases in children, has received an award from Partners HealthCare Personalized Medicine (PHPM), affiliated with Harvard Medical School, Boston Children’s, Brigham and Women’s, and Massachusetts General hospitals.

READ MORE ›
alt_text

Tuesday, Jun 20 2017

Drug May Prevent Recurrence of Aggressive Cancer

An international team led by Hadassah Hospital Oncologist Dr. Amir Sonnenblick reveals that giving a drug called metformin to diabetic women with a particularly aggressive form of breast cancer may prevent its recurrence.

READ MORE ›
alt_text

Monday, Jun 19 2017

Women's Health Empowerment Summit: A Success

Attendees from coast to coast came together to learn, network, and identify strategic next steps for improving and protecting women's health at the Coalition for Women's Health Equity's Women's Health Empowerment Summit, convened by Hadassah.

READ MORE ›
alt_text

Monday, Jun 19 2017

A Call To Action from the Women's Health Empowerment Summit

The Coalition for Women’s Health Equity’s inaugural Women’s Health Empowerment Summit was a resounding success! In 2016, Hadassah founded the Coalition for Women's Health Equity -- a broad coalition of 23 women's and health organizations that promotes policies to address inequities in quality of care, funding and support, and gaps in women's health awareness.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More